Authorized purpose: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Clinical role
Diagnostic and interventional image post-processing
Images and patients
Radiological images; modality varies or is not specified in FDA list · N/A
Key limitation
Keep in mind: Capabilities depend on the installed software option and supported Siemens hardware/system configuration; the general clearance does not make every option available on every host.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: N/A Input: Medical images and network DICOM data for review and post-processing; supported options include angiographic cone-beam CT processing and TrueFusion ultrasound fusion.
Who uses it?Intended users: Physicians using image review and image-guided diagnosis, treatment planning or treatment control applications.
What does the software produce?Output: Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.
What is its most important limitation?Key limitation: Capabilities depend on the installed software option and supported Siemens hardware/system configuration; the general clearance does not make every option available on every host.
Clinical takeaway. Clinical role: Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Evidence takeaway. Evidence from the reviewed source record: FDA testing includes 180 expert-reference bone-mask cases, a separate 370-dataset bone-removal reader evaluation and a 40-dataset DynaCT MORE comparison. These validate specific processing options, not one product-wide disease-detection endpoint.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Medical-image viewing and post-processing for diagnosis, interventional treatment planning and treatment control.
Medical images and network DICOM data for review and post-processing; supported options include angiographic cone-beam CT processing and TrueFusion ultrasound fusion.
Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.
Capabilities depend on the installed software option and supported Siemens hardware/system configuration; the general clearance does not make every option available on every host.
FDA testing includes 180 expert-reference bone-mask cases, a separate 370-dataset bone-removal reader evaluation and a 40-dataset DynaCT MORE comparison. These validate specific processing options, not one product-wide disease-detection endpoint.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA testing includes 180 expert-reference bone-mask cases, a separate 370-dataset bone-removal reader evaluation and a 40-dataset DynaCT MORE comparison. These validate specific processing options, not one product-wide disease-detection endpoint.
No comparable product-wide sensitivity is established by the option-specific processing tests.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-05
No comparable product-wide specificity is established by the option-specific processing tests.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K254184 DynaCT Bone Removal validation
DesignStandalone segmentation comparison and separate clinical reader evaluation
Population180 reference-mask cases: 60 each thorax, abdomen and pelvis; separate 370 US/European datasets for reader evaluation
Scopeexact submission
Tested versionsyngo Application Software VE51A, DynaCT Bone Removal
Samplen=180
IndependenceSponsor or vendor study
K254184
Sample size denotes reference-mask cohort only; reader cohort is not added to it as a unique patient total.
DesignProspective multicenter non-inferiority comparison of sine-spin flat-detector CT with multidetector CT
PopulationAdults with suspected ischemic or hemorrhagic stroke and feasible noncontrast syngo DynaCT Sine Spin within four hours of reference CT
Scopeproduct family
Tested versionsyngo DynaCT Sine Spin; no VE51A linkage established
IndependenceSponsor or vendor study
NCT05458908
University Hospital Basel sponsor with Siemens Healthineers collaborator. Registry design context only; no trial result or exact-release diagnostic performance promoted.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Medical images and network DICOM data for review and post-processing; supported options include angiographic cone-beam CT processing and TrueFusion ultrasound fusion.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Processed images and application-specific guidance. VE51A changes include myScrew Path Assist, Embolization Guidance, TrueFusion, CleanEdge, DynaCT Bone Removal, DynaCT MORE, contour overlay and QuantWeb/3D interaction on ARTIS Touch.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Siemens Healthineers' corporate cybersecurity page states a Secure Development Lifecycle addressing pre-market and post-market phases for products under development and a range of existing offerings; a Cybersecurity Management Service maintaining a product security inventory (over 1,000 product versions and over 21,000 monitored software components) with security whitepapers, SBOMs and vulnerability assessments available to customers via teamplay Fleet; incident and vulnerability management channels; and that Siemens Healthineers AG maintains an independent certification of its global Cybersecurity Management System to ISO/IEC 27001:2022 extended by ISO/IEC 27701:2019, with the certificate referenced to the SGS directory. Vendor statement; no certificate or report was read.
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: Siemens Healthineers' own corporate-info page names Siemens Medical Solutions USA, Inc. (Malvern, PA), and its 2024 governance press release states Siemens Healthcare GmbH's business was transferred to Siemens Healthineers AG. Corporate program statement; exact-release scope is not established.
Siemens Healthineers' cybersecurity page states that its Cybersecurity Management Service maintains a product security inventory of over 1,000 product versions and over 21,000 monitored software components, with security whitepapers, SBOMs and vulnerability assessments delivered via teamplay Fleet, and that it operates incident and vulnerability management.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The page names Siemens Healthineers generally and does not scope these commitments to any specific product release; exact-release scope is not established.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Radiological images; modality varies or is not specified in FDA list
FDA source
Exact FDA submission
Checked 2026-09-05
Existing broad catalog category preserved: the software spans radiographic, fluoroscopic/angiographic and cone-beam CT applications, including ultrasound fusion; it is not solely a CT product.
Existing unassigned catalog anatomy preserved because the general indication is multi-application. Individual modules address spine, cardiovascular, neurovascular, thorax, abdomen and pelvis; N/A does not mean no anatomic use.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-05Last searched
13Fields reviewed
10Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
Stored trial metadata screened and indexed primary registry content reviewed. SPINNERS retained as family design context, not VE51A results. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, clinical trial registry, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-05 - Exact FDA submission
VE51A hardware, upgrade and individual-option prices were not established from reviewed sources; obtain an optionized quote.
Pricing model: Not verified - checked 2026-09-05 - Exact FDA submission
Bundled versus separately licensed options and support terms remain unresolved.
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "syngo Application Software reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-05 - Exact FDA submission
Role-specific VE51A option training and site acceptance materials were not established.
Synapse PACS 7.6.0 provides medical-image management and processing, including measurements, regional segmentation, clinical calculations, structured reports, comparison, fusion, and volume rendering to aid reading, interpretation, reporting, and treatment planning.
Modality
Radiological images; modality varies or is not specified in FDA list
Beijing Infervision Healthcare Medical Technology Co., Ltd.
Authorized purpose: InferOperate Suite supports trained healthcare professionals in reading, interpreting, reporting, and treatment planning from medical images, with the submission's machine-learning functions applied to adult chest, abdomen, and pelvis CT.
Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Chest; abdomen; pelvis; and general patient anatomy represented in supported images
Authorized purpose: Clever One is dental imaging software for trained professionals to view and interpret DICOM images from CT, panoramic, cephalometric, intraoral, and other imaging equipment, with two-dimensional analysis and three-dimensional visualization tools.
Modality
Radiological images; modality varies or is not specified in FDA list
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.